This review highlights that while new causative agents for drug-induced hyperthermia are being recognized, treatment remains primarily supportive.
Supportive care remains appropriate for drug-induced hyperthermia; leaves open whether emerging agents warrant targeted interventions.
PURPOSE OF REVIEW: To review the current literature describing drug-induced hyperthermia and its treatment. Specifically, five syndromes will be discussed: malignant hyperthermia, neuroleptic malignant syndrome, anticholinergic poisoning, sympathomimetic poisoning, and serotonin syndrome. RECENT FINDINGS: The most recent findings in the literature are the recognition of previously undescribed drugs or drug combinations that have lead to hyperthermia. Recent literature also attests to the potential morbidity and mortality of drug-induced hyperthermia. SUMMARY: Although the recognition of causative agents is increasing, the treatment of drug-induced hyperthermia remains unchanged and continues to be primarily supportive.
No takes yet. Share an insight, caveat, or question.
Halloran et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: